Cutting back the thickets of Biosimilars
01-03-2021
Biosimilars in Italy: a new regime
10-01-2017
Biosimilar cost savings yet to materialise, says healthcare organisation
26-08-2016
roschetzky / iStockphoto
Introducing more biosimilars could cut healthcare spending by $54 billion over the next ten years, a figure far higher than initially thought, a think tank and research organisation has claimed.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Rand Corporation, biosimilars, biologics, "Biosimilar Cost Savings in the US”; Zarxio, Amgen, Sandoz
